Inefficacy of selegiline in treatment of canine pituitary‐dependent hyper‐adrenocorticism

Abstract

Selegiline administration was safe and free of side-effects at the doses used, but did not satisfactorily control disease in pituitary-dependent hyperadrenocorticism affected dogs.